105 related articles for article (PubMed ID: 38718210)
1. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors.
Vo JB; Ramin C; Veiga LHS; Brandt C; Curtis RE; Bodelon C; Barac A; Roger VL; Feigelson HS; Buist DSM; Bowles EJA; Gierach GL; Berrington de González A
J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38718210
[TBL] [Abstract][Full Text] [Related]
2. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
[TBL] [Abstract][Full Text] [Related]
3. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
[TBL] [Abstract][Full Text] [Related]
4. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
[TBL] [Abstract][Full Text] [Related]
5. Heart failure after treatment for breast cancer.
Boekel NB; Duane FK; Jacobse JN; Hauptmann M; Schaapveld M; Sonke GS; Gietema JA; Hooning MJ; Seynaeve CM; Maas AHEM; Darby SC; Aleman BMP; Taylor CW; van Leeuwen FE
Eur J Heart Fail; 2020 Feb; 22(2):366-374. PubMed ID: 31721395
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study.
Abdel-Qadir H; Tai F; Croxford R; Austin PC; Amir E; Calvillo-Argüelles O; Ross H; Lee DS; Thavendiranathan P
Circ Heart Fail; 2021 Jul; 14(7):e008110. PubMed ID: 34187164
[TBL] [Abstract][Full Text] [Related]
7. Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
Chen J; Long JB; Hurria A; Owusu C; Steingart RM; Gross CP
J Am Coll Cardiol; 2012 Dec; 60(24):2504-12. PubMed ID: 23158536
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab.
Banke A; Fosbøl EL; Ewertz M; Videbæk L; Dahl JS; Poulsen MK; Cold S; Jensen MB; Gislason GH; Schou M; Møller JE
JACC Heart Fail; 2019 Mar; 7(3):217-224. PubMed ID: 30819377
[TBL] [Abstract][Full Text] [Related]
9. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.
Greenlee H; Iribarren C; Rana JS; Cheng R; Nguyen-Huynh M; Rillamas-Sun E; Shi Z; Laurent CA; Lee VS; Roh JM; Santiago-Torres M; Shen H; Hershman DL; Kushi LH; Neugebauer R; Kwan ML
J Clin Oncol; 2022 May; 40(15):1647-1658. PubMed ID: 35385342
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.
Tsai HT; Isaacs C; Fu AZ; Warren JL; Freedman AN; Barac A; Huang CY; Potosky AL
Breast Cancer Res Treat; 2014 Feb; 144(1):163-70. PubMed ID: 24469642
[TBL] [Abstract][Full Text] [Related]
13. An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study.
Yoodee J; Sookprasert A; Sanguanboonyaphong P; Chanthawong S; Seateaw M; Subongkot S
Clin Pract; 2021 Aug; 11(3):484-493. PubMed ID: 34449564
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
J Natl Cancer Inst; 2019 Aug; 111(8):854-862. PubMed ID: 30715404
[TBL] [Abstract][Full Text] [Related]
15. The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study.
Goldhar HA; Yan AT; Ko DT; Earle CC; Tomlinson GA; Trudeau ME; Krahn MD; Krzyzanowska MK; Pal RS; Brezden-Masley C; Gavura S; Lien K; Chan KK
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26476433
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab-containing regimens for metastatic breast cancer.
Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
[TBL] [Abstract][Full Text] [Related]
17. Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study.
Hubbert L; Mallios P; Karlström P; Papakonstantinou A; Bergh J; Hedayati E
Front Oncol; 2023; 13():1095251. PubMed ID: 37152049
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women: A Nationwide Cohort Study.
Chien HC; Kao Yang YH; Bai JP
JAMA Oncol; 2016 Oct; 2(10):1317-1325. PubMed ID: 27310478
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study.
Thavendiranathan P; Abdel-Qadir H; Fischer HD; Camacho X; Amir E; Austin PC; Lee DS
J Clin Oncol; 2016 Jul; 34(19):2239-46. PubMed ID: 27091709
[TBL] [Abstract][Full Text] [Related]
20. Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005.
Du XL; Xia R; Burau K; Liu CC
Med Oncol; 2011 Dec; 28 Suppl 1():S80-90. PubMed ID: 20967512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
